Discussing genetic predisposition results with your provider supports a more personalized conversation about which non-GLP-1 agent may warrant consideration first
A recent study has confirmed that the common ABCG2 variant Q141K, identified in human intervention cohort studies, is associated with an increased risk of hyperuricemia and gout
The master antioxidant glutathiones presence is essential to the health of the body
Schwartz EA, Koska J, Mullin MP, Syoufi I, Schwenke DC, Reaven PD
Good candidates for peptides for weight loss generally include people who have: A body mass index (BMI) of 30 or higher A BMI of 27 or higher paired with a weight-related health condition, such as high blood pressure, high cholesterol, or diabetes Ongoing struggles with stubborn belly fat or a slow metabolism Age-related fat gain, particularly common among men in their 30s, 40s, 50s, and beyond A weight-loss plateau despite staying consistent with exercise and a clean diet Weight gain linked to a hormonal imbalance or low testosterone Peptide therapy is not appropriate for everyone, however
Neutrophil injury and function alterations induced by high mechanical shear stress with short exposure time